The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...
The goal of genome editing technology is to develop strategies for the correction of those mutations that are responsible of ...
This approval was followed by Takeda Pharmaceuticals’ Alofisel (darvadstrocel), which received approval from the European Medicines Agency in 2018 and from Japan’s Pharmaceuticals and Medical Devices ...
Resilience relies on the brain’s ability to regulate emotion, adapt, and recover. Myelin plasticity helps speed up and stabilize resilient brain responses. Genes like FKBP5 and BDNF affect how people ...
After serving seven years as a therapy dog for the Loyola community, Ashlar plans to retire at the end of the semester, ...
Medical history has recently been made in a New York City hospital. This month, 21-year-old Sebastien Beauzile became the ...
Speakers from the Muscular Dystrophy Association (MDA) highlighted 75 years of progress in understanding and treating ...
With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...
Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...
21h
Zacks Investment Research on MSNHow to Play SRPT Stock After Patient Death Post DMD Therapy InfusionShares of Sarepta Therapeutics SRPT plunged nearly 24% last week after the company reported the death of a patient following ...
The Company is currently analyzing the case and will update the prescribing information for Elevidys to note this development.
Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results